North Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Hold
230
0.21% 76
2026
Q1
$212K Hold
230
0.18% 89
2025
Q4
$247K Sell
230
-1
-0.4% -$956 0.21% 74
2025
Q3
$176K Buy
231
+1
+0.4% +$744 0.14% 95
2025
Q2
$179K Hold
230
0.15% 84
2025
Q1
$190K Buy
+230
New +$191K 0.18% 76

Other funds holding LLY

North Capital's LLY Position: Q2 2026 in Review

North Capital held its Eli Lilly (LLY) position steady in Q2 2026 at 230 shares worth $276K. The position accounts for 0.21% of the portfolio, ranked #76.

North Capital first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • North Capital held 230 shares of Eli Lilly worth $276K as of Q2 2026.
  • North Capital left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.21% of North Capital's portfolio in Q2 2026, its #76 holding.
  • North Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on North Capital's 13F filing for Q2 2026, filed 14 Jul 2026.